Author Archives: Denise Bell
Phoenix PharmaLabs Announces New Investment Offering with Netcapital
Phoenix PharmaLabs (Phoenix), a Utah company developing potent, non-addictive treatments for pain and opioid and cocaine addictions, announced it has launched its second offering campaign on the Netcapital platform. This new offering follows a fund raise in 2019 of more than $1.1 million via Netcapital. Proceeds from this latest campaign will further support the development […]
BioUtah Joins Patient Groups Opposing MFN
BioUtah joined numerous patient advocates and healthcare providers in sending a letter to U.S. House and Senate leaders in opposition to the Trump administration’s Most-Favored-Nation (MFN) drug pricing rule. The letter, organized by The Part B Access for Seniors and Physicians (ASP) Coalition, stated that the MFN model for Medicare Part B drugs will “lead […]
Reddyport’s New Non-Invasive Ventilation Products to Allow Patient Communication/Oral Care is Funded Through Launch
ReddyPort has announced it has raised Seed Funding to support launch of its non-invasive ventilation (NIV) products in 2021. Tony Lair, the former CEO of NeoMed (acquired by Avanos), led the investment round with participation from existing and new investors, including Spring Bay Ventures and MedMountain Ventures. Tony Lair will join ReddyPort’s Board of Directors. […]
Medsential Offering an FDA EUA Approved COVID Point of Care Antibody Rapid Test
Medsential has announced that it is now offering COVID-19 IgM/IgG rapid antibody tests to point of care providers and is able to meet high demand. The test has recently received FDA emergency use authorization. “We are thrilled to have a point of care rapid antibody test now available. We know hospitals, medical offices, and other […]
ELITech’s COVID, Flu, RSV Multiplex Test Receives CE Mark
ELITech Group recently announced its SARS-CoV-2 Plus Elite MGB Kit received CE marking and has been released. The test kit was developed to distinguish SARS-CoV-2 from other respiratory viruses, including influenza A/B and respiratory syncytial virus types A/B that may have similar symptoms. It runs on the firm’s Elite InGenius platform, as well as other […]
Congress Passes $900 Billion COVID Stimulus Package While Trump Calls for $2,000 in Direct Payments
Both the House of Representatives and the Senate passed on Monday a more than $900 billion COVID-19 stimulus package. The long-awaited and much needed assistance comes after months of protracted wrangling between the parties. As of this writing, President Trump did not say he would veto the bill but he asked Congress to amend it […]
Congress Nears Deal on COVID-19 Stimulus Package
Leaders of both parties inched closer on Thursday to agreement on a COVID-19 stimulus package. The package would include more funding for PPP loans, allow a second loan draw for hard-hit small businesses and streamline forgiveness for loans of $150,000 or less. In addition, the measure is expected to include some level of direct payments […]
SDP Oncology Presents Data Evaluating Alvocidib in Patients with Acute Myeloid Leukemia and Other Updates on Development Programs at ASH 2020
Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently presented new data from the Phase 2 Zella 201 study evaluating the investigational agent alvocidib, a potent CDK9 inhibitor, in patients with MCL-1 dependent acute myeloid leukemia (AML). These results were presented at the 62nd American Society of Hematology Annual Meeting, which was held virtually December 5-8, […]
Utah Readies to Receive 154,000 COVID-19 Vaccines
Governor Herbert yesterday announced that teachers would move up to the front of the line for the COVID-19 vaccine. In addition to teachers, the first phase of vaccinations in Utah will focus on healthcare workers, as well as residents and staff of long-term care facilities. Last week, BioUtah sent a letter to the Utah Department […]
Drug Industry Trade Groups File Lawsuits on Most-Favored-Nation Pricing Rule
The Trump administration recently announced an interim final rule to implement the Most Favored Nation drug pricing model, which would tie prices of certain Medicare Part B drugs to the lowest prices paid in Organisation for Economic Cooperation and Development (OECD) countries. In response, drug industry trade groups have filed two lawsuits against the administration on December […]
Co-Diagnostics JV CoSara Receives Clearance from Indian FDA for COVID-19 2-Gene Multiplex Test
Co-Diagnostics announced November 25 that CoSara Diagnostics Pvt Ltd (“CoSara,” or the “JV”), its joint venture for manufacturing and sales in India, has received clearance by the Central Drugs Standard Control Organization (“CDSCO”) in India to manufacture and sell its Saragene™ COVID-19 2-gene multiplex RT-PCR test. Dwight Egan, CEO of Co-Diagnostics, said “tests built on […]
Utah COVID-19 Small Business Quarantined Employee Grants
Utah continues to support the business community during the COVID-19 pandemic with its COVID-19 Small Business Quarantined Employee Grant program. If an employee needs to quarantine or isolate due to a COVID-19 exposure or positive test, employers can continue paying them and be reimbursed with this grant program. Utah created this program to reimburse small […]
